| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.43 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |